Lysis of venous, pulmonary, prosthetic valvular, arterial, and ventricular clots.
Thrombolysis has been used for the treatment of diverse thrombotic conditions for almost 50 years. Treatment of deep venous thrombosis and pulmonary embolism have been extensively studied, and benefit has been demonstrated in some subgroups. More recently thrombolysis has been investigated for the treatment of prosthetic valvular, arterial, and ventricular mural thrombi.
D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003328:Coronary Thrombosis / Q000188:drug therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy; D013924:Thrombophlebitis / Q000188:drug therapy; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology
D005343:Fibrinolytic Agents